Cutia Therapeutics
WEBOur Mission. To Provide Consumers and Patients with a Comprehensive Suite of Alternative, Safe and Effective Solutions for Skin and Scalp Diseases, etc.
Cutia Therapeutics
WEBAddress: 中国上海市静安区恒丰路436号环智大厦20楼. Postal code: 200070. Tel: (86) 21 5298 2688. 关于我们. 公司简介. 企业管治. 董事及高级管理人员. 集团业务. 研发中心.
Company Profile – Cutia Therapeutics
WEBR&D-Driven Dermatology Platform. Our Mission. To Provide Consumers and Patients with a Comprehensive Suite of Alternative, Safe and Effective Solutions for Skin and Scalp Diseases, etc. Well-positioned in the broader dermatology treatment and care industry to capture market potential.
Cutia Therapeutics - PitchBook
WEBCutia Therapeutics is a dermatology-focused biopharmaceutical company focused on the broader dermatology treatment and care therapeutic areas, including localized adipose accumulation management medication, scalp diseases and care, skin diseases and care, and topical anesthesia.
Menlo and Cutia enter agreement for topical minocycline products
WEBApr 24, 2020 · Menlo Therapeutics announces its wholly-owned subsidiary Foamix Pharmaceuticals Ltd. is entering a licensing with Cutia Therapeutics for the company’s FDA-approved 4% topical minocycline foam (AMZEEQ, Foamix) for acne vulgaris in pediatric and adult patients.
Cutia Therapeutics’ Atopic Dermatitis Drug Advances - Nasdaq
WEBMay 30, 2024 · Cutia Therapeutics has announced the approval of their Investigational New Drug (IND) application for CU-10101, a topical small molecule agent aimed at treating mild to moderate atopic...
Menlo Therapeutics and Cutia Therapeutics Enter into Exclusive …
WEBApr 23, 2020 · VYNE. --Menlo Therapeutics Inc., a specialty pharmaceutical company focused on developing and commercializing proprietary therapies to address unmet needs in dermatology, today announced that its...
Cutia Therapeutics - Products, Competitors, Financials, …
WEBDec 6, 2023 · Cutia Therapeutics is a research and development-driven company in the dermatology sector. The company focuses on providing a comprehensive suite of alternative, safe, and effective solutions for skin and scalp diseases.
Cutia Therapeutics, Ltd. - Scrip
WEBJul 3, 2023 · Genrix grossed $478.9m in the largest initial public offering from an innovative drug-focused biotech on Shanghai's STAR Market since February 2022. Meanwhile, Laekna and Cutia launched two smaller IPOs in Hong Kong.
Duality Biologics
WEBDualityBio is a clinical stage company focusing on the discovery and development of the next generation ADC therapeutics to treat patients in cancer and autoimmune diseases.
- Some results have been removed